Announcements
- Immuron Board Changes
- Immuron CEO Steven Lydeamore to present at Peak Sky High
- Immuron Limited to Present at the Emerging Growth Conference
- Immuron Director Resignation
- Immuron to host Live Virtual Event
- Immuron Travelan® sales continued strong growth
- Immuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the US
- Immuron Presentation Australian Biologics Festival 2024
- Immuron achieves record Travelan® sales
- Immuron CEO, Steven Lydeamore Investor Webinar Presentation
More ▼
Key statistics
On Friday, Immuron Ltd (ANWG:DEU) closed at 0.058, 81.25% above the 52 week low of 0.032 set on Mar 04, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.0575 |
---|---|
High | 0.058 |
Low | 0.049 |
Bid | 0.0565 |
Offer | 0.0585 |
Previous close | 0.058 |
Average volume | 0.00 |
---|---|
Shares outstanding | 228.00m |
Free float | 187.04m |
P/E (TTM) | -- |
Market cap | 21.43m AUD |
EPS (TTM) | -0.017 AUD |
Data delayed at least 15 minutes, as of May 31 2024.
More ▼